Cubist Systematic Strategies’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-137,794	Closed	-$828K	–	4844
2022 Q4	$828K	Sell	137,794 -126,162	-48%	-$689K	0.01%	2623
2022 Q3	$1.54M	Buy	263,956 +200,133	+314%	+$1.25M	0.01%	2251
2022 Q2	$381K	Sell	63,823 -467,777	-88%	-$2.4M	﹤0.01%	3270
2022 Q1	$2.48M	Buy	+531,600	New	+$1.59M	0.02%	1304
2021 Q4	–	Sell	-18,203	Closed	-$54K	–	3777
2021 Q3	$54K	Sell	18,203 -33,084	-65%	-$90.1K	﹤0.01%	2831
2021 Q2	$128K	Buy	51,287 +26,266	+105%	+$63K	﹤0.01%	2685
2021 Q1	$73K	Buy	+25,021	New	+$81.7K	﹤0.01%	2695
2015 Q2	–	Sell	-3,168	Closed	-$57K	–	2280
2015 Q1	$57K	Buy	+3,168	New	+$71.3K	﹤0.01%	1741
2014 Q3	–	Sell	-2,760	Closed	-$78K	–	2030
2014 Q2	$78K	Buy	+2,760	New	+$82.9K	﹤0.01%	1360